Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Hikma Pharmaceuticals USA INC. recalls Ciprofloxacin Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: N-nitroso-ciprofloxacin results above the FDA recommended interim control limit.
Products
  • Ciprofloxacin Tablets
Where it was sold

US Nationwide

Nationwide

Units affected
20,335 bottles
About this recall
Ciprofloxacin Tablets, USP, 750 mg, 50-count bottle, Rx Only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 182400, Amman, 11118-Jordan, Distributed by: Hikma Pharmaceuticals USA Inc. Berkely Heights, NJ 07922, NDC 0143-9929-50